Pharmaceutical Society of Kenya warns against vaginal use of cetirizine

The Pharmaceutical Society of Kenya (PSK) has issued an urgent warning to the public regarding a dangerous social media trend involving the misuse of antihistamines. Women are reportedly inserting cetirizine allergy tablets into the vagina in an attempt to achieve "tightening" of the vaginal walls. Health officials have condemned the practice, noting that it is based on misleading information circulating online and poses significant health risks to those who follow the advice.

According to the PSK, cetirizine is an oral medication specifically designed for the treatment of allergic reactions and is not intended for vaginal application. The society emphasized that inserting these tablets can cause severe tissue injury, extreme dryness, and intense discomfort. Because the drug works by reducing secretions, its application to sensitive mucous membranes can lead to long-term medical complications and disrupt the natural biological balance of the reproductive system.

The trend has reportedly gained traction on various social media platforms, where users promote the drug as a way to enhance sexual pleasure. This misinformation has not only led to health concerns but has also caused a noticeable surge in the demand for cetirizine across Kenya. Pharmacists expressed concern that this artificial spike in demand could lead to shortages of the medication for patients who genuinely require it for legitimate respiratory or skin allergies.

The Pharmaceutical Society of Kenya is urging the public to ignore unverified health advice found online and to consult qualified healthcare professionals for matters related to reproductive health. They cautioned that following viral health "hacks" without medical supervision can have irreversible consequences. The society continues to monitor the situation to ensure that pharmacies provide appropriate counseling to consumers purchasing the drug.